We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Automated Immunoassay for Testosterone Evaluated

By LabMedica International staff writers
Posted on 21 Feb 2011
Print article
A new electrochemiluminescence testosterone immunoassay has been evaluated and compared with existing methods.

The competitive immunoassay uses high affinity sheep monoclonal testosterone-specific antibody, which is complexed with the serum samples, and after processing the chemiluminescent emissions are measured by a photomultiplier.

Scientists at the University Medical Center Göttingen, (German), collaborated with others medical centers to evaluate the second-generation electrochemiluminescence assay and compare it to a validated assay. The scientists investigated the within-run precision, total precision, and method comparisons to the former immunoassay and the liquid chromatography tandem mass spectrometry (LC-MS/MS) assay. They were also interested in establishing reference intervals for adults and children. Special attention was paid to females with acute renal failure.

The within-run precision and total precision were determined using five different and site-specific human serum pools and two quality control samples. The within-run imprecision ranged from 12.8 μg/L, (0.9%) to 0.23 μg/L (5.2%), and total imprecision ranged from 12.7 μg/L (2.2%) to 0.22 μg/L (8.5%). The recovery according to quality control sample target values was 2.51 μg/L (95.4%) at one center, and 6.30 μg/L (103.6%) at another.

The new Elecsys Testo II assay (Roche Diagnostics GmbH, Mannheim, Germany) was compared against the former Roche Elecsys Testo assay and to a validated LC-MS/MS assay. Precision was improved especially at concentrations below 2.0 μg/L when compared to the former Elecsys Testo assay. The measuring range of 0.12 μg/L to 15.0 μg/L fulfils clinical needs. The new Elecsys Testo II assay demonstrated superior agreement in comparison to the validated LC-MS/MS method indicating an improved specificity.

Surprisingly, some high testosterone concentrations were found in samples from female patients, as confirmed by LC-MS/MS, as these individuals were suffering from polycystic ovary (PCO) syndrome or even androgen-producing tumors. The authors noted that overestimated values, especially with the former Elecsys immunoassay as compared to LC-MS/MS, were found to be from patients suffering from end-stage renal disease undergoing hemodialysis. The study was published in February 2011, in Clinical Biochemistry.

Related Links:
University Medical Center Göttingen
Roche Diagnostics


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Troponin I Test
Quidel Triage Troponin I Test
New
TORCH Infections Test
TORCH Panel

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.